摘要
目的:探讨疏血通注射液联合巴曲酶治疗急性进展性脑梗死的疗效。方法:收治急性进展性脑梗死患者62例,随机分为试验组与参照组,各31例。两组均应用巴曲酶治疗,试验组在此基础上联合疏血通注射液治疗。结果:试验组临床治疗总有效率显著高于参照组(P<0.05),治疗后试验组的血液学指标改善效果更加理想(P<0.05)。结论:疏血通注射液联合巴曲酶治疗急性进展性脑梗死,其临床疗效比较显著,有助于提升临床治疗总有效率,改善患者的血液学指标。
Objective:To explore the therapeutic effect of Shuxuetong injection combined with batroxobin in the treatment of acute progressive cerebral infarction.Methods:62 patients with acute progressive cerebral infarction were randomly divided into the experimental group and the reference group,with 31 cases in each group.The two groups were treated with batroxobin,and the experimental group was combined with Shuxuetong injection on the basis of this treatment.Results:The total effective rate of the experimental group was significantly higher than that of the reference group(P<0.05).After the treatment,the improvement of hematology index of the experimental group was more ideal(P<0.05).Conclusion:Shuxuetong injection combined with batroxobin is effective in the treatment of acute progressive cerebral infarction,which helps to improve the total effective rate of clinical treatment and improve the hematological indexes of patients.
作者
王杰
Wang Jie(The People's Hospital of Fenggang County,Guizhou Province 564200)
出处
《中国社区医师》
2018年第12期84-84,86,共2页
Chinese Community Doctors
关键词
疏血通注射液
巴曲酶
急性进展性脑梗死
Shuxuetong injection
Batroxobin
Acute progressive cerebral infarction